サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1758068

心臓修復システムの世界市場

Cardiac Restoration Systems

出版日
ページ情報
英文 270 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
心臓修復システムの世界市場
出版日: 2025年06月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 270 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓修復システムの世界市場は2030年までに7億5,990万米ドルに達する見込み

2024年に6億70万米ドルと推定される心臓修復システムの世界市場は、2030年には7億5,990万米ドルに達し、分析期間2024-2030年のCAGRは4.0%で成長すると予測されます。本レポートで分析したセグメントの1つである僧帽弁修復システムは、CAGR 3.2％を記録し、分析期間終了時には4億5,860万米ドルに達すると予測されます。左心室修復システムセグメントの成長率は、分析期間でCAGR 5.3％と推定されます。

米国市場は1億6,370万米ドルと推定、中国はCAGR7.2％で成長予測

米国の心臓修復システム市場は、2024年に1億6,370万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億5,310万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.7%と3.1%と予測されています。欧州では、ドイツがCAGR 2.3%で成長すると予測されています。

世界の心臓修復システム市場- 主要動向と促進要因のまとめ

なぜ心臓修復システムが先進心不全治療の要として台頭しているのか？

心臓修復システムは、心不全や関連する心臓の構造的状態に苦しむ患者のための革新的な延命ソリューションとして、大きな支持を集めています。これらのシステムは、機能不全に陥った心臓、特に左心室の形状を整え、支え、補強することで、正常な形状を取り戻し、機能を改善し、うっ血性心不全に伴う症状を軽減するように設計されています。心血管系疾患は依然として世界の死因の第一位であり、何百万人もの人々が慢性心不全に罹患していることから、薬物療法や侵襲的な移植手術に代わる治療法が緊急に求められています。心機能回復は、内科的治療と補助人工心臓（VAD）や心臓移植のようなより積極的な治療との橋渡しをするものであり、そのような治療が適さない患者にとって特に価値のあるものです。心外膜インプラント、心室リモデリングデバイス、注射可能なバイオスカフォールドなどのシステムは、心臓の自然な解剖学的構造を大きく損なうことなく、心臓の機械的効率を回復させる。心臓発作後の生存率が向上するにつれて、より多くの患者が心臓の損傷による長期的な影響とともに生きるようになり、修復的アプローチに対する需要が高まっています。さらに、早期診断の改善、心臓病に対する意識の向上、新興国における心臓治療へのアクセスの改善により、これらの治療法の対象となる患者層が拡大しています。心臓修復システムは現在、心拍出量を改善するだけでなく、患者のQOLと機能的自立を高め、最終的にはヘルスケア利用率と入院コストを削減する、実行可能な長期的ソリューションとみなされています。

技術革新はどのように心臓修復装置の性能と適応性を高めているのか？

技術革新は、心臓修復システムの機能と精度を拡大し、より安全で、より効果的で、より広範な患者の解剖学的構造や疾患の進行に適応できるようにする上で、変革的な役割を果たしています。材料科学の開発により、心臓組織の力学を模倣した生体適合性と柔軟性に優れたインプラント材料が開発され、合併症のリスクが軽減され、心筋との一体化が促進されました。小型化と、経カテーテルシステムや画像誘導ナビゲーションなどの送達ツールの導入により、これらのデバイスの低侵襲な展開が可能になり、外科的外傷と回復時間が大幅に短縮されました。最新のシステムの中には、3Dプリンティングや患者固有のモデリングを用いて、患者固有の心室構造に基づいてインプラントをカスタマイズし、治療成績を向上させるものもあります。さらに、生体吸収性スキャフォールドや注入可能なハイドロゲルが開発されており、徐々に分解しながら組織の再生を促進し、除去の必要なく修復された心臓環境を残すことができます。リアルタイム画像技術や術中モニタリング技術との統合により、デバイスの正確な配置と機能の最適化が保証されます。さらに、修復システムに組み込まれたスマート素材やバイオセンサーは、デバイスの性能、圧力勾配、心機能に関するフィードバックを早期に提供し、データ駆動型の個別化治療の時代を切り開いています。これらの技術革新は、心臓修復システムの治療可能性を高めるだけでなく、早期の構造的悪化や併存疾患を有する心不全患者を含む、より広範な心不全患者への適用を拡大しつつあります。技術が進化し続けるにつれて、心臓修復術は現代の心不全管理の標準的な要素になりつつあります。

心臓修復システムの需要を形成しているヘルスケアの動向と臨床慣行とは？

ヘルスケア提供、臨床ガイドライン、患者の期待の変化は、世界の循環器ネットワークにおける心臓修復システムの導入に大きな影響を与えています。個別化医療や精密医療が重視されるようになり、臨床医は単に症状を管理するのではなく、心不全の根本的な機械的原因に対処する治療法をますます求めるようになっています。心臓修復システムは、収縮期心不全における心機能低下の主な要因である心室の拡張、壁の菲薄化、収縮力の低下を標的とすることで、この要求を満たします。循環器専門医，外科医，電気生理学者からなる集学的心臓治療チームの増加も，これらのシステムをより広範に評価し，標準治療プロトコールに組み込むことを容易にしています。さらに、心不全がすぐに終末期と診断されるのではなく、慢性的で管理可能な状態になるにつれて、患者の自立を維持し、繰り返しの入院や複雑なデバイス治療への依存を減らすために、心臓修復のような長期的な解決策が重要性を増しています。保険償還の枠組みは、特に再入院の減少や心臓移植の必要性の遅延や回避など、こうしたシステムのコスト削減の可能性を認識するように進化しています。また、より良い教育、ピアアドボカシー、患者を新たな治療選択肢につなげるデジタルヘルスプラットフォームによって、新規治療に対する患者の意識と意欲も高まっています。心臓修復デバイスの安全性と有効性を裏付ける臨床試験データはより強固なものとなり、医師が治療経路の早い段階でこれらのアプローチを採用するよう促しています。ヘルスケアがより積極的でアウトカム志向のモデルに移行するにつれて、構造矯正と機能回復を提供する心臓修復システムのような治療介入に対する需要は加速し続けると思われます。

心臓修復システムの世界市場成長の原動力は？

心臓修復システム市場の成長は、心不全の有病率の上昇、技術の進歩、良好な臨床結果、バリューベース・ケアに向けた戦略的推進など、いくつかの要因が交錯することによってもたらされます。世界的には、人口の高齢化と心筋梗塞後の生存率の上昇が、慢性的な心機能障害を抱える患者の増加に寄与しています。このような患者層の拡大は、完全な外科的置換術や機械的循環補助のようなリスクや制限を伴わずに、心機能の目に見える改善を提供するミッドレンジインターベンションに対する需要を煽っています。技術的な観点からは、画像処理、材料科学、デバイスの小型化における技術革新が、心臓修復システムをより利用しやすく、展開しやすくしており、学術的にも地域ヘルスケア環境においても、より広範な採用を可能にしています。良好な臨床試験データと、駆出率、運動能力、症状緩和の改善を実証する現実のエビデンスが、これらのデバイスの市場可能性をさらに検証しています。さらに、規制当局の経路はより合理化されつつあり、いくつかの機器はFDAなどの機関からCEマークの承認やファスト・トラックの指定を受け、市場への迅速な参入と普及を促進しています。財務面では、ヘルスケアシステムは、病院での再入院を減らし、慢性疾患を積極的に管理し、総ケアコストを下げるというインセンティブをますます強めています。医療機器企業、学術機関、病院ネットワーク間の戦略的協力関係も、技術革新と市場浸透に拍車をかけています。これらのダイナミクスを総合すると、持続的成長のための強固な基盤が形成されつつあり、心臓修復システムは進化する心不全治療の展望における重要なイノベーションとして位置づけられています。

セグメント

製品（僧帽弁修復システム、左心室修復システム）;エンドユース（病院エンドユース、外来手術センターエンドユース、その他エンドユース）

調査対象企業の例

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardiac Dimensions, Inc.
  • Cardiovascular Systems, Inc.
  • Corindus Vascular Robotics
  • Edwards Lifesciences
  • Endotronix, Inc.
  • Fresenius Medical Care
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Penumbra, Inc.
  • Shockwave Medical, Inc.
  • Siemens Healthineers
  • Spectranetics Corporation
  • Terumo Corporation
  • Zoll Medical Corporation

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中のドメイン専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36474

Global Cardiac Restoration Systems Market to Reach US$759.9 Million by 2030

The global market for Cardiac Restoration Systems estimated at US$600.7 Million in the year 2024, is expected to reach US$759.9 Million by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Mitral Valve Restoration Systems, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$458.6 Million by the end of the analysis period. Growth in the Left Ventricular Restoration Systems segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$163.7 Million While China is Forecast to Grow at 7.2% CAGR

The Cardiac Restoration Systems market in the U.S. is estimated at US$163.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$153.1 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Cardiac Restoration Systems Market - Key Trends & Drivers Summarized

Why Are Cardiac Restoration Systems Emerging as a Cornerstone in Advanced Heart Failure Treatment?

Cardiac restoration systems are gaining significant traction as innovative, life-extending solutions for patients suffering from heart failure and related structural heart conditions. These systems are designed to reshape, support, or reinforce the failing heart-particularly the left ventricle-to restore normal geometry, improve function, and reduce symptoms associated with congestive heart failure. As cardiovascular disease remains the leading cause of death globally, with millions affected by chronic heart failure, there is an urgent demand for therapeutic alternatives beyond pharmacological treatment and invasive transplant procedures. Cardiac restoration offers a bridge between medical management and more aggressive interventions like ventricular assist devices (VADs) or heart transplantation, making it particularly valuable for patients who are not suitable candidates for such procedures. Systems such as epicardial implants, ventricular remodeling devices, and injectable bio-scaffolds work to restore the mechanical efficiency of the heart without significantly compromising its natural anatomy. As survival rates post-heart attack improve, more patients are living with the long-term consequences of cardiac damage, driving demand for restorative approaches. Furthermore, improvements in early diagnosis, increased awareness of heart disease, and better access to cardiac care in emerging economies are broadening the patient pool eligible for these interventions. Cardiac restoration systems are now viewed as a viable long-term solution that not only improves cardiac output but also enhances patients' quality of life and functional independence, ultimately reducing healthcare utilization and hospitalization costs.

How Are Technological Innovations Enhancing the Performance and Adaptability of Cardiac Restoration Devices?

Technological innovation is playing a transformative role in expanding the capabilities and precision of cardiac restoration systems, making them safer, more effective, and increasingly adaptable to a wider range of patient anatomies and disease progressions. Advances in material science have led to the development of biocompatible and flexible implant materials that mimic cardiac tissue mechanics, reducing the risk of complications and enhancing integration with the myocardium. Miniaturization and the incorporation of delivery tools like transcatheter systems and image-guided navigation have enabled less invasive deployment of these devices, significantly reducing surgical trauma and recovery times. Some of the latest systems use 3D printing and patient-specific modeling to customize implants based on a patient’s unique ventricular structure, improving therapeutic outcomes. Furthermore, bioresorbable scaffolds and injectable hydrogels are being developed to promote tissue regeneration while gradually degrading, leaving behind a restored cardiac environment without the need for removal. Integration with real-time imaging and intraoperative monitoring technologies ensures precise device placement and function optimization. Additionally, smart materials and biosensors embedded in restoration systems are providing early feedback on device performance, pressure gradients, and cardiac function, ushering in the era of data-driven, personalized therapy. These innovations are not only enhancing the therapeutic potential of cardiac restoration systems but are also expanding their applicability across a broader spectrum of heart failure patients, including those with early-stage structural deterioration or coexisting comorbidities. As technology continues to evolve, cardiac restoration is poised to become a standard component of modern heart failure management.

What Healthcare Trends and Clinical Practices Are Shaping the Demand for Cardiac Restoration Systems?

Shifts in healthcare delivery, clinical guidelines, and patient expectations are significantly influencing the adoption of cardiac restoration systems across global cardiology networks. With the growing emphasis on personalized and precision medicine, clinicians are increasingly looking for treatment modalities that address the root mechanical causes of heart failure rather than simply managing symptoms. Cardiac restoration systems fulfill this demand by targeting ventricular dilation, wall thinning, and impaired contractility, which are key contributors to declining heart function in systolic heart failure. The rise in multidisciplinary heart teams, composed of cardiologists, surgeons, and electrophysiologists, is also facilitating broader evaluation and integration of these systems into standard care protocols. Furthermore, as heart failure becomes a chronic, manageable condition rather than an immediate terminal diagnosis, long-term solutions like cardiac restoration are gaining importance for maintaining patient independence and reducing reliance on repeated hospitalizations or complex device therapy. Reimbursement frameworks are evolving to recognize the cost-saving potential of these systems, particularly in reducing readmissions and delaying or avoiding the need for heart transplants. Patient awareness and willingness to pursue novel therapies have also increased, driven by better education, peer advocacy, and digital health platforms that connect patients to emerging treatment options. Clinical trial data supporting the safety and efficacy of cardiac restoration devices is becoming more robust, encouraging physicians to adopt these approaches earlier in the treatment pathway. As healthcare moves toward more proactive, outcome-oriented models, the demand for therapeutic interventions like cardiac restoration systems that offer structural correction and functional recovery will continue to accelerate.

What’s Driving the Growth of the Global Cardiac Restoration Systems Market?

The growth in the cardiac restoration systems market is driven by several intersecting factors, including the rising prevalence of heart failure, technological advancements, favorable clinical outcomes, and the strategic push toward value-based care. Globally, aging populations and increased survival rates following myocardial infarction are contributing to a larger patient base living with chronic cardiac dysfunction. This expanding population fuels the demand for mid-range interventions that offer tangible improvements in heart function without the risks or limitations of full surgical replacement or mechanical circulatory support. From a technological perspective, innovations in imaging, material science, and device miniaturization are making cardiac restoration systems more accessible and easier to deploy, allowing for broader adoption in both academic and community healthcare settings. Positive clinical trial data and real-world evidence demonstrating improvements in ejection fraction, exercise capacity, and symptom relief are further validating the market potential of these devices. Additionally, regulatory pathways are becoming more streamlined, with several devices gaining CE Mark approval or fast-track designations from agencies like the FDA, facilitating quicker market entry and adoption. On the financial front, healthcare systems are increasingly incentivized to reduce hospital readmissions, manage chronic conditions proactively, and lower the total cost of care-goals that align well with the function and promise of cardiac restoration therapy. Strategic collaborations between medical device companies, academic institutions, and hospital networks are also fueling innovation and market penetration. Altogether, these dynamics are creating a robust foundation for sustained growth, positioning cardiac restoration systems as a critical innovation in the evolving landscape of heart failure treatment.

SCOPE OF STUDY:

The report analyzes the Cardiac Restoration Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Mitral Valve Restoration Systems, Left Ventricular Restoration Systems); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardiac Dimensions, Inc.
  • Cardiovascular Systems, Inc.
  • Corindus Vascular Robotics
  • Edwards Lifesciences
  • Endotronix, Inc.
  • Fresenius Medical Care
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Penumbra, Inc.
  • Shockwave Medical, Inc.
  • Siemens Healthineers
  • Spectranetics Corporation
  • Terumo Corporation
  • Zoll Medical Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Cardiac Restoration Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Heart Failure Throws the Spotlight on Cardiac Restoration as a Transformative Therapy Option
    • Limitations of Conventional Treatments Accelerate Demand for Minimally Invasive Cardiac Restoration Systems
    • Expansion of Structural Heart Disease Programs Strengthens the Business Case for Ventricular Restoration Technologies
    • Aging Population and Higher Heart Disease Risk Profiles Sustain Long-Term Need for Cardiac Repair Solutions
    • Breakthroughs in Device-Based Therapies Propel Growth in Left Ventricular Restoration System Adoption
    • Patient Preference for Minimally Invasive Options Drives Adoption of Transcatheter-Based Restoration Platforms
    • Increased Clinical Trials and Real-World Data Enhance Confidence in Efficacy of Cardiac Restoration Devices
    • Hospital Focus on Readmission Reduction and Functional Improvement Supports Integration into Heart Failure Care Pathways
    • Rising Use of Cardiac MRI and Advanced Imaging Fuels Personalized Planning for Restoration Procedures
    • Surge in Advanced Heart Failure Referrals Spurs Market Demand for Bridge-to-Recovery Solutions
    • Integration with Digital Health Tools and Remote Monitoring Strengthens Post-Procedure Outcome Tracking
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Restoration Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiac Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mitral Valve Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mitral Valve Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Mitral Valve Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Left Ventricular Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Left Ventricular Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Left Ventricular Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Cardiac Restoration Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Cardiac Restoration Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Cardiac Restoration Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Cardiac Restoration Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION